Coronavirus CPD resources 

COVID-19 clinical practice & medicines-related information

We're updating this resource regularly.

If we've missed anything or it needs updating, email [email protected]

You may also want to visit the main RPS COVID-19 hub for the latest alerts, support and information on our campaigning.

Hot off the press!

I want to learn about:

Additional training and learning:


Basics of Critical Care

Helping you step up to support your critical care colleagues.

Handbook: Introduction to Critical Care

ICU guide image

 

For pharmacists who are new to providing pharmacy services in the critical care setting. It will provide a brief understanding of the critical care patient, the environment, and some of the tools you will need to provide a basic but solid clinical review.

Click on the cover to download version 2.




Q&A Webinar: Sedation, Medicines Reconciliation, Renal impairment

Watch our webinar recording from 26 March with UKCPA Critical Care Committee Experts speakers:

  • Greg Barton, Specialist Pharmacist in Critical Care and Burns
  • Mark Borthwick, Consultant Pharmacist Critical Care

Critical Care Pharmacy Q&A from Royal Pharmaceutical Society on Vimeo.

Other resources

Back to the top

Common conditions 

Managing patients that you don’t usually see, in any setting.

We recommend that you revisit the management of common acute and chronic conditions seen in practice. Here is a handy list from our Core Professional Knowledge Guides:

  • Clotting disorders – DVT and PE
  • Atrial Fibrillation – management and prevention of complications
  • Heart failure – with reduced ejection fraction and with preserved ejection fraction
  • Hypertension and hypercholesterolaemia
  • Ischaemic heart disease
  • Diabetes – Type 1, Type 2, gestational, alcohol or steroid induced
  • Stroke – haemorrhagic and ischaemic
  • Asthma and COPD
  • Dementia and Parkinson’s disease
  • Common infections – respiratory, urinary tract, skin and soft tissue
  • Depression
  • Chronic pain

Get to know your references:

bnf-bnfc_fd3a754d-e4dc-498d-9a72-0cabae737fc3


Download the BNF app from your mobile device app store for easy to access and up-to-date drug monographs. Access is free within the UK. See our overview here.



Find out if your organisation has access to MedicinesComplete, or a current version of Medicines, Ethics and Practice.


Other resources to refresh your knowledge:

  • Oxford Handbook of Clinical Pharmacy: RPS members can access for free in our e-library -There are helpful chapters on therapy-related issues, including: Cardiovascular disease, respiratory system, infections, endocrine, pain, palliative care
  • Clinical Medication Review: A Practical Guide (2014) – a useful guide to medicines review and identifying medicines-related problems (Specialist Pharmacy Services)

Back to the top

Transitioning to hospital practice

Helping you get familiar with clinical roles in the hospital setting.

Back to the top

Clinical management of COVID-19

Overview:

  • BMJ Best Practice: Coronavirus disease 2019 (COVID-19) – online or PDF
    This resource describes what to expect in terms of clinical presentation, diagnostics, and management

Experimental therapies

A message from Professor Gino Martini, Chief Scientist for the Royal Pharmaceutical Society:

The COVID 19 pandemic has initiated a global hunt for an effective treatment or prophylactic by the pharmaceutical industry and research institutions. A number of companies are revamping older antivirals, some developing new antivirals whilst others are repurposing drugs or researching for new vaccines and monoclonal antibodies.Never have we seen such a global concerted effort to deal with such a deadly contagion. Due to the very limited robust data on efficacy and safety, we do not currently endorse these potential treatments for novel coronavirus (COVID 19) outside a controlled research environment. We are monitoring the emerging research and will continue to update our members of developments.

NHS position statement - Management of COVID-19 in adults with investigational agents: Interim Support for clinicians in England

The evidence-base in this area is rapidly changing. Take this into account when using the following resources: 

 

Diagnostic testing 

 

 Drug safety  

ACEI/ARB:

NSAIDs

 

Other evidence-based summaries

Back to the top

COVID-19 in special populations

Guidance for patients with specific conditions during the COVID-19 pandemic.

 
NICE & NHS guidance:
  • NHS specialty guides for patient management.
    These cover key service delivery considerations for patient populations and services in the NHS.
  • NICE COVID-19 rapid guidelines:
    • Critical care – there is a handy flowchart that summarises the critical care admission algorithm
    • Dialysis service delivery
    • Delivery of systemic anticancer treatments

 

Other guidance: 

  • Patients on warfarin: 

warfarin icon637209246867965493

Guidance for the safe switching of warfarin to direct oral anticoagulants (DOACs) for patients with non-valvular AF and venous thromboembolism (DVT/PE) during the coronavirus pandemic (26 March)

Helen Williams, Lead Author and Consultant Pharmacist for CVD: “A number of associations and societies across the UK have come together to provide guidance on the safe switching of warfarin to DOACs  This needs to be undertaken in a phased manner over the 12 week cycle of INR monitoring to protect the supply chain for ALL patients.  As highlighted, many patients are not suitable for a switch from warfarin to DOACs and further guidance will be available shortly to support services providing care for these patients.” 


Respiratory – British Thoracic Society

-Community respiratory services (23 March) and resource pack for transitioning to remote delivery of pulmonary rehabilitation
-Interstitial Lung Disease (23 March)
-Obstructive sleep apnoea (20 March)
-Lung function testing (TBA from Association for Respiratory Technology & Physiology)
-Information for respiratory patients

UK guidance:
-Critical care preparation and management in the COVID-19 pandemic (Joint guidance from The Faculty of Intensive Care Medicine, Intensive Care Society, Association of Anaesthetists, and Royal College of Anaesthetists): There are 6 key pharmacy-specific recommendations in the Operational section
-Critical Care FAQ and advice


International guidance:
-Surviving Sepsis Campaign: Guidelines on Management of Critically Ill Adults with Coronavirus Disease2019

  • Endocrine:

-From the Society for Endocrinology: Considerations for those with thyroid dysfunction, thyroid cancer, and osteoporosis on zolendronic acid treatment
-Diabetes: Diabetes UK ‘sick day’ rules

 Back to the top

Shortages

Recommendations for hospital departments:

 

Back to the top

Return to practice training

Watch this space.

Back to the top